Form 144 - Report of proposed sale of securities:
SEC Accession No. 0000947871-23-001098
Filing Date
2023-11-22
Accepted
2023-11-22 16:07:09
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3122
  Complete submission text file 0000947871-23-001098.txt   4662
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
ORBIMED ADVISORS LLC (Reporting) CIK: 0001055951 (see all company filings)

EIN.: 133976876 | State of Incorp.: DE
Type: 144

Mailing Address ONE RESEARCH WAY PRINCETON NJ 08540
Business Address ONE RESEARCH WAY PRINCETON NJ 08540 (609) 642-6664
PMV Pharmaceuticals, Inc. (Subject) CIK: 0001699382 (see all company filings)

EIN.: 463218129 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-39539 | Film No.: 231433460
SIC: 2834 Pharmaceutical Preparations